TrialIndian heart journal

Efficacy of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in right ventricular systolic dysfunction and preserved LV ejection fraction: A randomized clinical trial.

Rohit Mathur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.